Basic Information
RNALocate ID: RLID:11003000
RNA Symbol: hsa-miR-495-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-495-3p
RNA ID: miRBase:MIMAT0002817
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 24683445
Tissue/Cell Line: Plasma
Method: Next-generation RNA sequencing
Description: Exosomes are enriched with miRNA: Small RNA libraries of the samples described above were constructed for small RNA-seq by NGS. The number of miRNA identified in this study was 943 of 2,233 known mature miRNA from miRBase V.20. Mapping to Ensembl Release 74 was performed to identify other non-coding RNA such as tRNA, rRNA, small nucleolar RNA (snoRNA) and LincRNA. The average across all 3 samples was calculated to obtain a representative profile of biological diversity between patients (standard deviations of reads in Supplementary file).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002337 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:11002998 Exosome Brain tissue 23382797
RLID:11002999 Exosome Plasma 23663360
RLID:11003001 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000484 Microvesicle Blood|Fibroblasts|Mesenchymal stem cells|Urine
RLID-D:11001249 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-495-3p Oral squamous cell carcinoma MNDR-E-MI-54671
MNDR hsa-miR-495-3p Medulloblastoma MNDR-E-MI-54672
MNDR hsa-miR-495-3p High-grade serous ovarian carcinoma MNDR-E-MI-54673
MNDR hsa-miR-495-3p Uterine corpus endometrial carcinoma MNDR-E-MI-54674
MNDR hsa-miR-495-3p Estrogen-receptor positive breast cancer MNDR-E-MI-54675
MNDR hsa-miR-495-3p Estrogen-receptor negative breast cancer MNDR-E-MI-54676
MNDR hsa-miR-495-3p Progesterone-receptor positive breast cancer MNDR-E-MI-54677
MNDR hsa-miR-495-3p Progesterone-receptor negative breast cancer MNDR-E-MI-54678
MNDR hsa-miR-495-3p Her2-receptor positive breast cancer MNDR-E-MI-54679
MNDR hsa-miR-495-3p Autosomal recessive limb-girdle muscular dystrophy type 2a MNDR-E-MI-54680
MNDR hsa-miR-495-3p Autosomal recessive limb-girdle muscular dystrophy type 2b MNDR-E-MI-54681
MNDR hsa-miR-495-3p Dermatomyositis MNDR-E-MI-54682
MNDR hsa-miR-495-3p Prostate cancer MNDR-E-MI-54683
MNDR hsa-miR-495-3p Gastric cancer MNDR-E-MI-54684
MNDR hsa-miR-495-3p Alzheimer disease MNDR-E-MI-54685
MNDR hsa-miR-495-3p Bladder cancer MNDR-E-MI-54686
MNDR hsa-miR-495-3p Esophageal carcinoma MNDR-E-MI-54687
MNDR hsa-miR-495-3p Dysautonomia familial MNDR-E-MI-54688
MNDR hsa-miR-495-3p Distal muscular dystrophy MNDR-E-MI-54689
MNDR hsa-miR-495-3p Duchenne muscular dystrophy MNDR-E-MI-54690
MNDR hsa-miR-495-3p Leukemia MNDR-E-MI-54691
MNDR hsa-miR-495-3p Cardiovascular disease MNDR-E-MI-54692
MNDR hsa-miR-495-3p Dilated cardiomyopathy MNDR-E-MI-54693
MNDR hsa-miR-495-3p Lung cancer MNDR-E-MI-54694
MNDR hsa-miR-495-3p Endometrial cancer MNDR-E-MI-54695
MNDR hsa-miR-495-3p Parkinson disease MNDR-E-MI-54696
MNDR hsa-miR-495-3p Breast cancer MNDR-E-MI-54697
MNDR hsa-miR-495-3p Squamous cell carcinoma MNDR-E-MI-54698
MNDR hsa-miR-495-3p Thyroid cancer MNDR-E-MI-54699
MNDR hsa-miR-495-3p Pancreatic cancer MNDR-E-MI-54700
MNDR hsa-miR-495-3p Melanoma MNDR-E-MI-54701
MNDR hsa-miR-495-3p Nephroblastoma MNDR-E-MI-54702
MNDR hsa-miR-495-3p Colon cancer MNDR-E-MI-54703
MNDR hsa-miR-495-3p Colon adenocarcinoma MNDR-E-MI-54704
MNDR hsa-miR-495-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-54705
MNDR hsa-miR-495-3p Familial ovarian cancer MNDR-E-MI-54706
MNDR hsa-miR-495-3p Prostate adenocarcinoma MNDR-E-MI-54707
MNDR hsa-miR-495-3p Carcinoma ductal breast MNDR-E-MI-54708
MNDR hsa-miR-495-3p Glioblastoma MNDR-E-MI-54709
MNDR hsa-miR-495-3p Malignant glioma MNDR-E-MI-54710
MNDR hsa-miR-495-3p Nemaline myopathy MNDR-E-MI-54711
MNDR hsa-miR-495-3p Amyotrophic lateral sclerosis MNDR-E-MI-54712
MNDR hsa-miR-495-3p Temporal lobe epilepsy MNDR-E-MI-54713
MNDR hsa-miR-495-3p Osteosarcoma MNDR-E-MI-54714
MNDR hsa-miR-495-3p Coronary artery disease MNDR-E-MI-54715
MNDR hsa-miR-495-3p Breast carcinoma MNDR-E-MI-54716
MNDR hsa-miR-495-3p Gastric adenocarcinoma MNDR-E-MI-54717
MNDR hsa-miR-495-3p Cervical squamous cell carcinoma MNDR-E-MI-54718
MNDR hsa-miR-495-3p Bone-invasive pituitary adenoma MNDR-E-MI-54719
MNDR hsa-miR-495-3p Carcinoma lung non-small-cell MNDR-E-MI-54720
MNDR hsa-miR-495-3p Adrenocortical carcinoma MNDR-E-MI-54721
MNDR hsa-miR-495-3p Thyroid carcinoma MNDR-E-MI-54722
MNDR hsa-miR-495-3p Ovarian carcinoma MNDR-E-MI-54723
MNDR hsa-miR-495-3p Bladder urothelial carcinoma MNDR-E-MI-54724
MNDR hsa-miR-495-3p Pancreatic adenocarcinoma MNDR-E-MI-54725
MNDR hsa-miR-495-3p Carcinoma renal cell MNDR-E-MI-54726
MNDR hsa-miR-495-3p Kidney renal papillary cell carcinoma MNDR-E-MI-54727
MNDR hsa-miR-495-3p Renal clear cell carcinoma MNDR-E-MI-54728
MNDR hsa-miR-495-3p Cholangiocarcinoma MNDR-E-MI-54729
MNDR hsa-miR-495-3p Lung small cell carcinoma MNDR-E-MI-54730
MNDR hsa-miR-495-3p Synovial sarcoma MNDR-E-MI-54731
MNDR hsa-miR-495-3p Head and neck squamous cell carcinoma MNDR-E-MI-54732
MNDR hsa-miR-495-3p Breast invasive carcinoma MNDR-E-MI-54733
MNDR hsa-miR-495-3p Familiar ovarian carcinoma MNDR-E-MI-54734
MNDR hsa-miR-495-3p Periodontitis MNDR-E-MI-54735
MNDR hsa-miR-495-3p Salivary gland cancer MNDR-E-MI-54736
MNDR hsa-miR-495-3p Acute myeloid leukemia with mixed lineage leukemia MNDR-E-MI-54737
MNDR hsa-miR-495-3p Colorectal cancer MNDR-E-MI-54738
MNDR hsa-miR-495-3p Nasopharynx carcinoma MNDR-E-MI-54739
MNDR hsa-miR-495-3p Ovarian epithelial cancer MNDR-E-MI-54740
MNDR hsa-miR-495-3p Nasopharyngeal cancer MNDR-E-MI-54741
MNDR hsa-miR-495-3p Aids dementia complex MNDR-E-MI-54742
MNDR hsa-miR-495-3p Muscular disorders atrophic MNDR-E-MI-54743
MNDR hsa-miR-495-3p Breast cancer her3+ negative MNDR-E-MI-54744
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABCB1 Homo sapiens RR00022790
TOP